Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This clinical trial will compare the mean first year height velocity of somatropin-treated
prepubertal patients with SHOX deficiency with the height velocity of a control group of
untreated prepubertal patients with SHOX deficiency. Both groups will be compared to a
somatropin-treated group of girls with Turner syndrome. After the second year patients in the
control group have the option to receive treatment as well. All patients will optionally be
treated until they achieved adult height.